Literature DB >> 26627731

Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis.

Pourya Masoudian1, Ahmed Nasr2, Joseph de Nanassy1, Karen Fung-Kee-Fung3, Shannon A Bainbridge4, Dina El Demellawy5.   

Abstract

The purpose of this study was to determine whether pregnancies that were achieved via oocyte donation, compared with pregnancies achieved via other assisted reproductive technology methods or natural conception, demonstrate increased risk of preeclampsia or gestational hypertension. Comparative studies of pregnancies that were achieved with oocyte donation vs other methods of assisted reproductive technology or natural conception with preeclampsia or gestational hypertension were included as 1 of the measured outcomes. Abstracts and unpublished studies were excluded. Two reviewers independently selected studies, which were assessed for quality with the use of methodological index for non-randomized studies, and extracted the data. Statistical analysis was conducted. Of the 523 studies that were reviewed initially, 19 comparative studies met the predefined inclusion and exclusion criteria and were included in the metaanalysis, which allowed for analysis of a total of 86,515 pregnancies. Our pooled data demonstrated that the risk of preeclampsia is higher in oocyte-donation pregnancies compared with other methods of assisted reproductive technology (odds ratio, 2.54; 95% confidence interval, 1.98-3.24; P < .0001) or natural conception (odds ratio, 4.34; 95% confidence interval, 3.10-6.06; P < .0001). The risk of gestational hypertension was also increased significantly in oocyte donation pregnancies in comparison with other methods of assisted reproductive technology (odds ratio, 3.00; 95% confidence interval, 2.44-3.70; P < .0001) or natural conception (odds ratio, 7.94; 95% confidence interval, 1.73-36.36; P = .008). Subgroup analysis that was conducted for singleton and multiple gestations demonstrated a similar risk for preeclampsia and gestational hypertension in both singleton and multiple gestations. This metaanalysis provides further evidence that supports that egg donation increases the risk of preeclampsia and gestational hypertension compared with other assisted reproductive technology methods or natural conception.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  gestational hypertension; oocyte donation; preeclampsia

Mesh:

Year:  2015        PMID: 26627731     DOI: 10.1016/j.ajog.2015.11.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

1.  The impact of using donor sperm in assisted reproductive technology cycles on perinatal outcomes.

Authors:  Bo Yu; Rani Fritz; Xianhong Xie; Abdissa Negassa; Sangita Jindal; Mario Vega; Erkan Buyuk
Journal:  Fertil Steril       Date:  2018-12       Impact factor: 7.329

Review 2.  A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Donatella Spotti; Franca Giacchino; Rossella Attini; Monica Limardo; Stefania Maxia; Antioco Fois; Linda Gammaro; Tullia Todros
Journal:  J Nephrol       Date:  2017-04-22       Impact factor: 3.902

Review 3.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

Review 4.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 5.  Emerging role for dysregulated decidualization in the genesis of preeclampsia.

Authors:  Kirk P Conrad; Maria Belen Rabaglino; Emiel D Post Uiterweer
Journal:  Placenta       Date:  2017-06-09       Impact factor: 3.481

6.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

7.  Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data.

Authors:  Bo Yu; Mario Vega; Sahar Zaghi; Rani Fritz; Sangita Jindal; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2018-08-20       Impact factor: 3.412

8.  In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters.

Authors:  Barbara Luke; Morton B Brown; Michael L Eisenberg; Caitriona Callan; Beverley J Botting; Allan Pacey; Alastair G Sutcliffe; Valerie L Baker
Journal:  Am J Obstet Gynecol       Date:  2019-10-17       Impact factor: 8.661

9.  Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis.

Authors:  Costas Thomopoulos; George Salamalekis; Konstantinos Kintis; Iliana Andrianopoulou; Helena Michalopoulou; George Skalis; Stefanos Archontakis; Ourania Argyri; Costas Tsioufis; Thomas K Makris; Emmanuel Salamalekis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-07       Impact factor: 3.738

10.  Maternal Vascular Health in Pregnancy and Postpartum After Assisted Reproduction.

Authors:  Frauke von Versen-Höynck; Sebastian Häckl; Elif Seda Selamet Tierney; Kirk P Conrad; Valerie L Baker; Virginia D Winn
Journal:  Hypertension       Date:  2019-12-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.